@article{5046,
  author = {Ekaterina Galkina Cleary and Matthew J. Jackson and Fred D. Ledley},
  title = {Government as the First Investor in Biopharmaceutical Innovation: Evidence From New Drug Approvals 2010–2019},
  abstract = {The discovery and development of new medicines classically involves a linear process of basic biomedical research to uncover potential targets for drug action, followed by applied, or translational, research to identify candidate products and establish their effectiveness and safety.},
  year = {2020},
  journal = {Institute for New Economic Thinking Working Paper Series},
  pages = {1-72},
  month = {2020-9-1},
  url = {https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3731819},
  doi = {10.36687/inetwp133},
  language = {en},
}